Sur, Cyrille
Merck & Co., Inc., Rahway, NJ, USA (United States)
8 papers on CoChat
Most cited papers
- Verified
Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype
McKernan, R. M., Rosahl, T. W., Reynolds, D. S., Sur, C., Wafford, K. A., Atack, J. R., Farrar, S., Myers, J., Cook, G., Ferris, P., et al. (2000) · Nature Neuroscience
Neuroscience and Neuropharmacology ResearchNicotinic Acetylcholine Receptors Study
Cited by 944
- Verified
Randomized trial of verubecestat for mild-to-moderate Alzheimer's disease
Egan, M. F., Kost, J., Tariot, P. N., Aisen, P. S., Cummings, J. L., Vellas, B., Sur, C., Mukai, Y., Voss, T., Furtek, C., et al. (2018) · New England Journal of Medicine
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 685
- Verified
Enhanced Learning and Memory and Altered GABAergic Synaptic Transmission in Mice Lacking the α5 Subunit of the GABA A Receptor
Collinson, N., Kuenzi, F. M., Jarolimek, W., Maubach, K. A., Cothliff, R., Sur, C., Smith, A., Otu, F. M., Howell, O., Atack, J. R., et al. (2002) · The Journal of Neuroscience
Neuroscience and Neuropharmacology ResearchMemory and Neural Mechanisms
Cited by 628
- Verified
Randomized trial of verubecestat for prodromal Alzheimer's disease
Egan, M. F., Kost, J., Voss, T., Mukai, Y., Aisen, P. S., Cummings, J. L., Tariot, P. N., Vellas, B., van Dyck, C. H., Boada, M., et al. (2019) · New England Journal of Medicine
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 545
- Verified
Sedation and Anesthesia Mediated by Distinct GABA A Receptor Isoforms
Reynolds, D. S., Rosahl, T. W., Cirone, J., O'Meara, G. F., Haythornthwaite, A., Newman, R. J., Myers, J., Sur, C., Howell, O., Rutter, A. R., et al. (2003) · The Journal of Neuroscience
Anesthesia and Sedative AgentsNeuroscience and Neuropharmacology Research
Cited by 318
- Verified
TPA023 [7-(1,1-Dimethylethyl)-6-(2-ethyl-2 H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an Agonist Selective for α2- and α3-Containing GABAA Receptors, Is a Nonsedating Anxiolytic in Rodents and Primates
Atack, J. R., Wafford, K. A., Tye, S. J., Cook, S. M., Sohal, B., Pike, A., Sur, C., Melillo, D., Bristow, L., Bromidge, F., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics
Neuroscience and Neuropharmacology ResearchPharmacological Receptor Mechanisms and Effects
Cited by 188
- Verified
Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with 18F-MK-6240, a PET Tracer Targeting Neurofibrillary Tangles
Lohith, T. G., Bennacef, I., Vandenberghe, R., Vandenbulcke, M., Salinas, C. A., Declercq, R., Reynders, T., Telan-Choing, N. F., Riffel, K., Celen, S., et al. (2019) · Journal of Nuclear Medicine
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 107
- Verified
A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [18F]flutemetamol amyloid PET images
Bucci, M., Savitcheva, I., Farrar, G., Salvadó, G., Collij, L., Doré, V., Gispert, J. D., Gunn, R., Hanseeuw, B., Hansson, O., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 50
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free